1WHO. Weekly epidemiological record [J]. WER, 2009, 84(14): 109-116.
2Roberts L. Polio eradication. Rethinking the polio endgame [J]. Science, 2009, 323 (5915): 705.
3Tano Y, Shimizu H, Martin J, et al. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenu- ated Sabin strains [J]. Vaccine, 2007, 25 (41):7041-7046.
4Urakawa T, Ferguson M, Miuor PD, et al. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector [J]. J Gen Virol, 1989, 70 (Pt6): 1453-1463.
5Brautigam S, Snezhkov E, Bishop DH. Formation of poliovirus- like particles by recombinant baculoviruses expressing the individual VP0,VP3 and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein[J]. Virology, 1993, 192 (2): 512-524.
6WHO. Weekly Epidemiological Record . 2009
7WHO.WHO global action plan for laboratory containment of wildpolioviruses. . 2002
8WHO.New polio vaccines for the post-eradication era. . 2000
9Heinsbroek E,Ruitenberg EJ.The global introduction of inacti-vated polio vaccine can circumvent the oral polio vaccine para-dox. Vaccine . 2010
10WHO.Inactivated poliovirus vaccine following goral poliovirus vaccine cessation. WER . 2006
